Literature DB >> 19524178

Systolic and diastolic function in patients with systemic sclerosis.

Laura Poanta1, Razvan Dadu, Cristina Tiboc, Simona Rednic, Dan Dumitrascu.   

Abstract

BACKGROUND: Clinical and epidemiological findings indicate that symptomatic heart disease in patients with systemic sclerosis (SSc) predicts poor prognosis, but cardiac involvement may occur years before clinical manifestation. The aim of this study was to evaluate the cardiac function in patients with SSc and to correlate the echocardiographic parameters with others that quantify the diseases' severity.
METHODS: Twenty consecutive patients with SSc were investigated with transthoracic echocardiography (TTE). Two dimensional, pulsed Doppler and pulsed tissue Doppler imaging (TDI) techniques were used, in all the patients, to assess the systolic and diastolic function for left ventricle (LV). Correlations were made between echocardiographic measurements and some clinical and serological features of the patients.
RESULTS: None of the patients had any clinical signs of cardiac involvement, nor ECG or TTE systolic function impairment; there are significant differences between systemic sclerosis patients and control group for peak A velocity (0.75+/-0.22 vs 0.57+/-0.32, P=0.05), E/A ratio (1.14+/-0.22 vs 1.48+/-0.26, P=0.01), E/Ea ratio (8.25+/-1.57 vs 7+/-2.2, P=0.05), which account for filling impairment of LV. There are also significant correlations between some other parameters, like the mean duration of Raynaud's phenomenon and E/Ea ratio (r=0.48, P<0.05).
CONCLUSIONS: The analysis of SSc heart disease, mainly at a preclinical level, is important in all the cases as an asymptomatic patient may have diastolic dysfunction which can be treated and should be closely observed.

Entities:  

Mesh:

Year:  2008        PMID: 19524178     DOI: 10.1016/j.ejim.2008.10.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  9 in total

Review 1.  N-TproBNP as biomarker in systemic sclerosis.

Authors:  Tommaso Schioppo; Carolina Artusi; Teresa Ciavarella; Francesca Ingegnoli; Antonella Murgo; Silvana Zeni; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

3.  Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.

Authors:  Matthew R Lammi; Lesley A Saketkoo; Jessica K Gordon; Paula Lauto; Karen Fagan; Virginia D Steen
Journal:  Respirology       Date:  2017-05-12       Impact factor: 6.424

4.  Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients.

Authors:  Francesco Masini; Raffaele Galiero; Pia Clara Pafundi; Klodian Gjeloshi; Emanuele Pinotti; Roberta Ferrara; Ciro Romano; Luigi Elio Adinolfi; Ferdinando Carlo Sasso; Giovanna Cuomo
Journal:  J Scleroderma Relat Disord       Date:  2021-06-07

5.  Autonomic dysfunction predicts early cardiac affection in patients with systemic sclerosis.

Authors:  Khaled M Othman; Naglaa Youssef Assaf; Hanan Mohamed Farouk; Iman M Aly Hassan
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-05-24

6.  Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; Kenneth McDonald; David Keane; Jonathan D Dodd
Journal:  Insights Imaging       Date:  2010-10-19

Review 7.  Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.

Authors:  Peter Glynn; Sarah Hale; Tasmeen Hussain; Benjamin H Freed
Journal:  Front Cardiovasc Med       Date:  2022-03-31

8.  Heart diastolic dysfunction in patients with systemic sclerosis.

Authors:  Michał Ciurzyński; Piotr Bienias; Katarzyna Irzyk; Maciej Kostrubiec; Agnieszka Szewczyk; Urszula Demkow; Maria Siwicka; Katarzyna Kurnicka; Barbara Lichodziejewska; Piotr Pruszczyk
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

9.  Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.

Authors:  Makoto Sano; Hiroshi Satoh; Kenichiro Suwa; Mamoru Nobuhara; Takeji Saitoh; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Kumiko Shimoyama; Daisuke Suzuki; Noriyoshi Ogawa; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2014-07-05       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.